Condition
Spinal Fusion Acquired
Total Trials
4
Recruiting
0
Active
0
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 17/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
75%
3 trials in Phase 3/4
Results Transparency
50%
1 of 2 completed with results
Key Signals
1 with results100% success
Data Visualizations
Phase Distribution
4Total
Not Applicable (1)
P 4 (3)
Trial Status
Completed2
Not Yet Recruiting1
Unknown1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT06607081Not ApplicableNot Yet Recruiting
Preoperative Risk Evaluation and Per ERAS Intervention in the Chinese Elderly Patients Underwent Spinal Fusion Surgery
NCT02631408Phase 4CompletedPrimary
Intrawound Vancomycin Powder in Spinal Fusion Surgery
NCT00808665Phase 4CompletedPrimary
Intraoperative Infusion of Precedex to Reduce Length of Stay After Lumbar Spine Fusion
NCT02466048Phase 4UnknownPrimary
Efficacy and Safety of SurgiFill™ on Spinal Fusion
Showing all 4 trials